Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Reexamination Certificate
2006-08-15
2006-08-15
Nguyen, Dave Trong (Department: 1633)
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
C435S239000, C435S456000, C435S320100, C435S069100, C424S093200, C536S023100, C536S024100
Reexamination Certificate
active
07091029
ABSTRACT:
The invention includes methods and compositions for the production of high titer recombinant adeno-associated virus (rAAV). The disclosed rAAV are useful in gene therapy applications. Methods are based on the use of recombinant herpes virus vectors and result in highly efficient production of rAAV.
REFERENCES:
patent: 5965441 (1999-10-01), Breakefield et al.
patent: 6383794 (2002-05-01), Mountz et al.
patent: 6596269 (2003-07-01), Iadarola et al.
patent: 6686200 (2004-02-01), Dong et al.
patent: 2002/0051769 (2002-05-01), Zhang
patent: 2002/0058341 (2002-05-01), Nakai et al.
Knipe, D. “The Role of Viral and Cellular Nuclear Proteins in Herpes Simplex Virus Replication,” Advances in Virus Research, vol. 37: 85-123, 1989.
Clark, K. “Recent Advances in Recombinant Adeno-Associated Virus Vector Production,” Kidney International, vol. 61, Symposium 1 (2002): S9-S15, 2002.
Rutledge, et al., “Infectious Clones and Vectors Derived From Adeno-Associated Virus (AAV) Serotypes Other Than AAV Type 2,” Journal of Virology, vol. 72: 309-319, 1998.
Xiao, et al., “Gene Therapy Vectors Based on Adeno-Associated Virus Type 1,” Journal of Virology, vol. 73: 3994-4003, 1999.
Chiorini, et al., “Cloning and Characterization of Adeno-Associated Virus Type 5,” Journal of Virology, vol. 73: 1309-1319, 1999.
Chiorini, et al., “Cloning of Adeno-Associated Virus Type 4 (AAV4) and Generation of Recombinant AAV4 Particles,” Journal of Virology, vol. 71: 6823-6833, 1997.
Xiao, et al., “Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus,” Journal of Virology, vol. 72: 2224-2232, 1998.
Herzog, et al., “Stable Gene Transfer and Expression of Human Blood Coagulation Factor IX After Intramuscular Injection of Recombinant Adeno-Associated Virus,” Proc. Natl. Acad. Sci. USA, vol. 94: 5804-5809, 1997.
Hermonat, et al., “Use of Adeno-Associated Virus as a Mammalian DNA Cloning Vector: Transduction of Neomycin Resistance into Mammalian Tissue Culture Cells,” Proc. Natl. Acad. Sci. USA, vol. 81: 6466-6470, 1984.
Conway, et al., “Recombinant Adeno-Associated Virus Type 2 Replication and Packaging Is Entirely Supported by a Herpes Simplex Virus Type 1 Amplicon Expressing Rep and Cap,” Journal of Virology, vol. 71: 8780-8789, 1997.
Zolotukhin, et al., “Recombinant Adeno-Associated Virus Purification Using Novel Methods Improves Infectious Titer and Yield,” Gene Therapy, vol. 6: 973-985, 1999.
Halbert, et al., “Transduction by Adeno-Associated Virus Vectors in the Rabbit Airway: Efficiency, Persistence, and Readministration,” Journal of Virology, vol. 71: 5932-5941, 1997.
Conway, et al., “High-Titer Recombinant Adeno-Associated Virus Production Utilizing a Recombinant Herpes Simplex Virus Type I Vector Expressing AAV-2 Rep and Cap,” Gene Therapy, vol. 6: 986-993, 1999.
Monahan, et al., “Direct Intramuscular Injection With Recombinant AAV Vectors Results in Sustained Expression in a Dog Model of Hemophilia,” Gene Therapy, vol. 5: 40-49, 1998.
Matsushita, et al., “Adeno-Associated Virus Vectors can be Efficiently Produced Without Helper Virus,” Gene Therapy vol. 5: 938-945, 1998.
Koeberl, et al., “Persistent Expression of Human Clotting Factor IX From Mouse Liver After Intravenous Injection of Adeno-Associated Virus Vectors,” Proc. Natl. Acad. Sci. USA, vol. 94: 1426-1431, 1997.
Kessler, et al., “Gene Delivery to Skeletal Muscle Results in Sustained Expression and Systemic Delivery of a Therapeutic Protein,” Proc. Natl. Acad. Sci. USA, vol. 93: 14082-14087, 1996.
Nakai, et al., “Adeno-Associated Viral Vector-Mediated Gene Transfer of Human Blood Coagulation Factor IX into Mouse Liver,” Blood, vol. 91: 4600-4607, 1998.
Clark, et al., “Cell Lines for the Production of Recombinant Adeno-Associated Virus,” Human Gene Therapy vol. 6: 1329-1341, 1995.
Gao, et al., “High-Titer Adeno-Associated Viral Vectors From a Rep/Cap Cell Line and Hybrid Shuttle Virus,” Human Gene Therapy vol. 9: 2353-2362, 1998.
Johnston, et al., “HSV/AAV Hybrid Amplicon Vectors Extend Transgene Expression in Human Glioma Cells,” Human Gene Therapy vol. 8: 359-370, 1997.
Buller, et al., “Herpes Simplex Virus Types 1 and 2 Completely Help Adenovirus-Associated Virus Replication,” Journal of Virology, vol. 40: 241-247, 1981.
McCarthy, et al., “Herpes Simplex Virus Type 1 ICP27 Deletion Mutants Exhibit Altered Patterns of Transcription and are DNA Deficient,” Journal of Virology, vol. 63, 18-27, 1989.
Samulski, et al., “Rescue of Adeno-Associated Virus From Recombinant Plasmids: Gene Correction Within the Terminal Repeats of AAV,” Cell, vol. 33: 135-143, 1983.
Kaplitt, et al., “Long-Term Gene Expression and Phenotypic Correction Using Adeno-Associated Virus Vectors in the Mammalian Brain,” Nature Genetics, vol. 8: 148-154, 1994.
Sandri-Goldin, et al., “A Herpesvirus Regulatory Protein Appears to Act Post-Transcriptionally by Affecting mRNA Processing,” Genes & Development, vol. 6: 848-863, 1992.
Wagner, et al., “Efficient and Persistent Gene Transfer of AAV-CFTR in Maxillary Sinus,” The Lancet, vol. 351: 1702-1703, 1998.
Rice, et al., “Genetic Evidence for Two Distinct Transactivation Functions of the Herpes Simplex Virus α Protein ICP27,” Journal of Virology, vol. 64, 1704-1715, 1990.
Weindler, et al., “A Subset of Herpes Simplex Virus Replication Genes Provides Helper Functions for Productive Adeno-Associated Virus Replication,” Journal of Virology, vol. 65, 2476-2483, 1991.
Ye, et al., “Regulated Delivery of Therapeutic Proteins After in Vivo Somatic Cell Gene Transfer,” Science, vol. 283: 88-91, 1999.
Rose, et al., “Adenovirus-Associated Virus Multiplication VII. Helper Requirement for Viral Deoxyribonucleic Acid and Ribonucleic Acid Synthesis,” Journal of Virology, vol. 10: 1-8, 1972.
Snyder, et al., “Efficient and Stable Adeno-Associated Virus-Mediated Transduction in the Skeletal Muscle of Adult Immunocompetent Mice,” Human Gene Therapy, vol. 8: 1891-1900, 1997.
Hauswirth, et al., “Production and Purification of Recombinant Adeno-Associated Virus,” Methods In Enzymology, vol. 316: 743-761, 2000.
Flotte, et al., “Adeno-Associated Virus Vectors for Gene Therapy of Cystic Fibrosis,” Methods In Enzymology, vol. 292: 717-732, 1998.
Muzyczka, et al., “Parvoviridae: The Viruses and Their Replication,” Fields Virology, Fourth Edition, 2327-2359, 2001.
Muzyczka, N., “Use of Adeno-Associated Virus as a General Transduction Vector for Mammalian Cells,” Curr. Top Microbiol. Immunol., 158: 97-129, 1992.
Applied Genetics Technologies Corporation
Corless, Esq. Peter F.
Marvich Maria
McLaren, Esq. Margaret J.
Nguyen Dave Trong
LandOfFree
High titer recombinant AAV production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High titer recombinant AAV production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High titer recombinant AAV production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3657409